# Pharma Equity Group A/S

> Clarifo company profile — qualitative business description generated from
> the company's filings. Financial statements, charts and ratios are
> available on Clarifo (https://www.clarifo.com/en/companies/pharmaequitygroup).

## Overview

Pharma Equity Group A/S is a Danish listed company based in Hørsholm. The available filing excerpt confirms it prepares IFRS financial statements and presents consolidated interim reporting in Danish kroner, but it does not provide enough information to verify the group’s operating business, products, or end markets from the supplied context.

## Products & services

{"• Insufficient information to verify operating products or services","• IFRS interim and annual reporting in Danish kroner","• Listed-company corporate structure in Denmark"}

- **Unverified operating business** (100%) — Operating products or services are not disclosed in the provided context.

- Insufficient information to verify operating products or services
- IFRS interim and annual reporting in Danish kroner
- Listed-company corporate structure in Denmark

## Customers

The provided information does not disclose identifiable customer groups, buyers, or end markets. As a result, the company’s revenue model and customer base cannot be verified from the supplied excerpts. Any further segmentation would be speculative.

- **Undisclosed** (primary) — No customer or end-market disclosure was provided in the available context.

- Customer base not disclosed in the provided context
- End markets cannot be verified from the supplied excerpts
- Buyer types and purchase reasons are not disclosed

## Geography

Pharma Equity Group A/S is identified as a Danish company, and the interim report was approved in Hørsholm. Beyond Denmark, the supplied excerpts do not disclose operating countries, sales regions, or manufacturing locations, so broader geographic exposure cannot be verified.

- Domiciled in Denmark
- Interim report approved in Hørsholm
- No sales or operating geography disclosed in the excerpts

## Strategy

The supplied material does not describe the company’s commercial strategy, portfolio focus, or operating priorities. The only verifiable strategic context is that the group continues to prepare IFRS-based interim reporting on a going-concern basis.

- No operating strategy disclosed in the provided excerpts
- No portfolio, market, or product priorities available
- Going-concern financial reporting continues under IFRS

## Risks

Because the company’s operating business is not described in the available context, company-specific business risks cannot be reliably identified. The main verifiable risk signals are disclosure-related: investors cannot assess customer concentration, geographic exposure, product dependence, or operating leverage from the excerpt alone.

- **Undisclosed operating model** [high] — The excerpt does not identify products, customers, or markets, limiting risk assessment.
- **Unknown customer concentration** [high] — Without customer disclosure, dependence on a small number of buyers cannot be evaluated.

- Operating business and product risks are not disclosed
- Customer and revenue concentration cannot be assessed
- Geographic exposure is not disclosed
- Company-specific risk profile cannot be verified

## Accounting

The filing states that the interim statements are prepared under IFRS as adopted by the EU, using historical cost except where otherwise disclosed, and presented in DKK. Beyond that, no critical accounting estimates, revenue-recognition policies, impairment judgments, or segment-specific accounting matters were disclosed in the provided excerpt.

- **IFRS reporting basis** — Affects comparability and the presentation of the interim financial statements
- **Functional and presentation currency** — Currency presentation affects translation and investor interpretation

- IFRS as adopted by the EU
- Presentation currency is Danish kroner (DKK)
- Historical cost basis unless otherwise disclosed
- No material estimates or judgment areas disclosed

---

*Last updated: 2026-10-24T15:15:42.183978+00:00*